Moderna Inc.’s COVID-19 vaccine was highly effective in 12 to 17 year-old adolescents in a large study, paving the way for regulatory submissions around the world by early June. The company said its vaccine was between 93%…
- Advertisement -
Moderna Inc.’s COVID-19 vaccine was highly effective in 12 to 17 year-old adolescents in a large study, paving the way for regulatory submissions around the world by early June. The company said its vaccine was between 93%…